Patent application number | Description | Published |
20120288160 | IMAGE ANALYSIS FOR DETERMINING CHARACTERISTICS OF ANIMALS - Systems and methods are disclosed for predicting one or more characteristics of a animal by applying computational methods to image(s) of the animal to generate one or more metrics indicative of the characteristics. Embodiments determine predictors of characteristics by creating a sample library of animals of a particular type, determining facial descriptor measurements for each animal, determining relationships between facial descriptor measurements and additional library data, and selecting predictors from these relationships. Other embodiments predict characteristics of animals not in the library and, optionally, categorize animals for particular discipline, training, management, care, etc. based on the characteristics. Other embodiments predict characteristics and determine strategies for group(s) of animals using predicted characteristics of individual animals. Embodiments are broadly applicable to domesticated animals including dogs, cats, cattle, oxen, llamas, sheep, goats, camels, geese, horses, chickens, turkeys, and pigs. Other embodiments predict certain characteristics of humans, including certain cognitive or developmental disorders. | 11-15-2012 |
20120288170 | IMAGE ANALYSIS FOR DETERMINING CHARACTERISTICS OF HUMANS - Systems and methods are disclosed for predicting one or more characteristics of a animal by applying computational methods to image(s) of the animal to generate one or more metrics indicative of the characteristics. Embodiments determine predictors of characteristics by creating a sample library of animals of a particular type, determining facial descriptor measurements for each animal, determining relationships between facial descriptor measurements and additional library data, and selecting predictors from these relationships. Other embodiments predict characteristics of animals not in the library and, optionally, categorize animals for particular discipline, training, management, care, etc. based on the characteristics. Other embodiments predict characteristics and determine strategies for group(s) of animals using predicted characteristics of individual animals. Embodiments are broadly applicable to domesticated animals including dogs, cats, cattle, oxen, llamas, sheep, goats, camels, geese, horses, chickens, turkeys, and pigs. Other embodiments predict certain characteristics of humans, including certain cognitive or developmental disorders. | 11-15-2012 |
20130259332 | IMAGE ANALYSIS FOR DETERMINING CHARACTERISTICS OF GROUPS OF INDIVIDUALS - Embodiments include methods for predicting one or more characteristics of an individual, such as a human or non-human animal, by applying computational methods to image(s) of the individual to generate one or more metrics indicative of the characteristics. Embodiments determine predictors of characteristics by creating a sample library of individuals, determining facial measurements for each individual, determining relationships between facial measurements and additional library data, and selecting predictors from these relationships. Embodiments include methods for predicting characteristics of individuals not in the library. Embodiments include methods for predicting characteristics of groups using predicted characteristics of individuals. Embodiments determine suitability of a pair of individuals (from the same or different species) for a particular purpose, task, or relationship based on characteristics of individuals. Other embodiments determine the compatibility of an individual with a group of other individuals. Embodiments include systems, devices, and computer-readable media comprising one or more of these methods. | 10-03-2013 |
20130259333 | IMAGE ANALYSIS FOR DETERMINING CHARACTERISTICS OF INDIVIDUALS - Embodiments include methods for predicting one or more characteristics of an individual, such as a human or non-human animal, by applying computational methods to image(s) of the individual to generate one or more metrics indicative of the characteristics. Embodiments determine predictors of characteristics by creating a sample library of individuals, determining facial measurements for each individual, determining relationships between facial measurements and additional library data, and selecting predictors from these relationships. Embodiments include methods for predicting characteristics of individuals not in the library. Embodiments include methods for predicting characteristics of groups using predicted characteristics of individuals. Embodiments determine suitability of a pair of individuals (from the same or different species) for a particular purpose, task, or relationship based on characteristics of individuals. Other embodiments determine the compatibility of an individual with a group of other individuals. Embodiments include systems, devices, and computer-readable media comprising one or more of these methods. | 10-03-2013 |
20130259369 | IMAGE ANALYSIS FOR DETERMINING CHARACTERISTICS OF PAIRS OF INDIVIDUALS - Embodiments include methods for predicting one or more characteristics of an individual, such as a human or non-human animal, by applying computational methods to image(s) of the individual to generate one or more metrics indicative of the characteristics. Embodiments determine predictors of characteristics by creating a sample library of individuals, determining facial measurements for each individual, determining relationships between facial measurements and additional library data, and selecting predictors from these relationships. Embodiments include methods for predicting characteristics of individuals not in the library. Embodiments include methods for predicting characteristics of groups using predicted characteristics of individuals. Embodiments determine suitability of a pair of individuals (from the same or different species) for a particular purpose, task, or relationship based on characteristics of individuals. Other embodiments determine the compatibility of an individual with a group of other individuals. Embodiments include systems, devices, and computer-readable media comprising one or more of these methods. | 10-03-2013 |
Patent application number | Description | Published |
20120225470 | METHODS OF PROPAGATING MONKEY ADENOVIRAL VECTORS - The invention provides methods for propagating a monkey adenovirus in a cell including a human cell, comprising one or more gene products isolated from a human adenovirus. Also provided are methods for propagating wherein the monkey adenovirus comprises a nucleic acid sequence encoding a human adenovirus gene product. The invention further provides a monkey adenovirus. including a replication-deficient monkey adenovirus, obtained by such propagation methods. | 09-06-2012 |
20130337008 | ADENOVIRAL VECTOR-BASED DENGUE FEVER VACCINE - The invention relates to a replication-deficient adenoviral vector comprising two or more nucleic acid sequences encoding Dengue virus antigens and a chimeric hexon protein. The chimeric hexon protein comprises a first portion and a second portion. The first portion comprises at least 10 contiguous amino acid residues from a first adenovirus serotype (e.g., serotype 5 adenovirus hexon protein), optionally with one amino acid substitution. The second portion comprises (a) at least one hypervariable region (HVR) of a hexon protein of an adenovirus of a second adenovirus serotype, or (b) at least one synthetic hypervariable region (HVR) that is not present in the hexon protein of the wild-type adenovirus of the first adenovirus serotype. | 12-19-2013 |
20140248307 | AFFENADENOVIRUS (GORILLA) OR ADENOVIRAL VECTORS AND METHODS OF USE - The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein. | 09-04-2014 |
20140248308 | AFFENADENOVIRUS (GORILLA) OR ADENOVIRAL VECTORS AND METHODS OF USE - The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein. | 09-04-2014 |
20140271711 | ADENOVIRAL VECTOR-BASED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE - The invention provides an adenovirus or adenoviral vector characterized by comprising a nucleic acid sequence encoding one or more Respiratory Syncytial Virus (RSV) antigens and one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein, as well as a method of inducing an immune response against RSV in a mammal by administering the adenovirus or adenoviral vector to the mammal. | 09-18-2014 |
20140314717 | SIMIAN (GORILLA) ADENOVIRUS OR ADENOVIRAL VECTORS AND METHODS OF USE - The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein. | 10-23-2014 |
20150157700 | ADENOVIRAL VECTOR-BASED MALARIA VACCINE - The invention provides an adenovirus or adenoviral vector characterized by comprising a nucleic acid sequence encoding one or more | 06-11-2015 |
20150297699 | MALARIA ANTIGENS AND METHODS OF USE - The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against | 10-22-2015 |
20150329834 | METHODS OF PROPAGATING MONKEY ADENOVIRAL VECTORS - The invention provides methods for propagating a monkey adenovirus in a cell, including a human cell, comprising one or more gene products isolated from a human adenovirus. Also provided are methods for propagating wherein the monkey adenovirus comprises a nucleic acid sequence encoding a human adenovirus gene product. The invention further provides a monkey adenovirus, including a replication-deficient monkey adenovirus, obtained by such propagation methods. | 11-19-2015 |
Patent application number | Description | Published |
20090018100 | MATERIALS AND METHODS FOR TREATING OCULAR-RELATED DISORDERS - The present invention is directed to a method of prophylactically or therapeutically treating an animal for at least one ocular-related disorder, e.g., ocular neovascularization or age-related macular degeneration. The method comprises contacting an ocular cell with an expression vector comprising a nucleic acid sequence encoding an inhibitor of angiogenesis and the same or different nucleic acid sequence encoding a neurotrophic agent. The method also can comprise contacting an ocular cell with different expression vectors, each comprising a nucleic acid sequence encoding an inhibitor of angiogenesis and/or a nucleic acid sequence encoding a neurotrophic agent. In addition, the present invention provides a viral vector comprising a nucleic acid sequence encoding pigment epithelium-derived factor (PEDF) or a therapeutic fragment thereof. | 01-15-2009 |
20090041759 | Materials and methods for treating ocular-related disorders - The invention is directed to a method of delivering a gene product to an animal. The method comprises administering an expression vector comprising a nucleic acid sequence operably linked to a promoter and encoding a gene product, and upregulating transcription of the nucleic acid sequence in the ocular cell. The expression vector can be an adenoviral vector. The invention further provides a method of prophylactically or therapeutically treating an animal for at least one ocular-related disorder. The method comprises contacting an ocular cell with an expression vector comprising a nucleic acid sequence encoding an inhibitor of angiogenesis and/or a neurotrophic agent. In one aspect, the method further comprises upregulating transcription of the nucleic acid sequence. Preferably, if 2×10 | 02-12-2009 |
20090148477 | ADENOVIRAL VECTOR-BASED MALARIA VACCINES - The invention provides adenoviral vectors comprising an adenoviral genome comprising heterologous antigen-encoding nucleic acid sequences, such as | 06-11-2009 |
20100222234 | Malaria antigen screening method - The invention provides a method of identifying an antigen from a pathogen or a disease antigen comprising the use of an adenoviral vector array comprising two or more different adenoviral vectors, wherein each adenoviral vector comprises a nucleic acid sequence encoding a different antigen of a pathogen. The adenoviral vectors are administered to antigen presenting cells (APCs) in vitro or to an animal in vivo. The immunogenicity of the antigen is measured by screening for an immune response from effector T lymphocytes in vitro and by screening for the absence of pathogen-induced disease onset in vivo. | 09-02-2010 |
20140314809 | MALARIA ANTIGEN SCREENING METHOD - The invention provides a method of identifying an antigen from a pathogen or a disease antigen comprising the use of an adenoviral vector array comprising two or more different adenoviral vectors, wherein each adenoviral vector comprises a nucleic acid sequence encoding a different antigen of a pathogen. The adenoviral vectors are administered to antigen presenting cells (APCs) in vitro or to an animal in vivo. The immunogenicity of the antigen is measured by screening for an immune response from effector T lymphocytes in vitro and by screening for the absence of pathogen-induced disease onset in vivo. | 10-23-2014 |
Patent application number | Description | Published |
20080279722 | TRANSPORTABLE DECONTAMINATION UNIT AND DECONTAMINATION PROCESS - The disclosed invention relates to a portable decontamination unit. The invention also relates to a decontamination process. The decontamination unit may be ruggedized for use in hostile environments such as those that may be anticipated for military applications. | 11-13-2008 |
20090263501 | ACTIVATED OXIDIZING VAPOR TREATMENT SYSTEM AND METHOD - An oxidizing liquid ( | 10-22-2009 |
20090311152 | ACTIVATED VAPOR TREATMENT FOR NEUTRALIZING WARFARE AGENTS - Hydrogen peroxide is vaporized ( | 12-17-2009 |
20100074804 | APPARATUS FOR DEACTIVATING A PATHOGENIC CHEMICAL AGENT - Hydrogen peroxide is vaporized ( | 03-25-2010 |
20110076189 | FEED BACK AND DOSE CONTROL OF DISTRIBUTED DECONTAMINATION SYSTEMS - A sterilization system includes a plurality of vaporizers that are controlled by a network of interconnected controllers. The network includes a plurality of control units with each control unit controlling an associated vaporizer to adjust independently the rate at which the associated vaporizer injects vaporized sterilant into the different regions of an enclosure. The network also includes a master control unit configured to control each control unit over the network to coordinate the aggregate injection of sterilant vapor. | 03-31-2011 |
20120121462 | TRANSPORTABLE DECONTAMINATION UNIT AND DECONTAMINATION PROCESS - The disclosed invention relates to a portable decontamination unit. The invention also relates to a decontamination process. The decontamination unit may be ruggedized for use in hostile environments such as those that may be anticipated for military applications. | 05-17-2012 |
20120156095 | DECONTAMINANT DISPENSER SUITABLE FOR USE AS A PROJECTILE - The disclosed invention relates to a decontaminant dispenser which may be used as a projectile. The invention also relates to a decontamination process using the decontaminant dispenser. The decontaminant dispenser may be thrown by hand, launched as an artillery shell or the payload for a missile, or dropped by an airplane into the area to be decontaminated. The dispenser may be placed in the area to be decontaminated. The decontaminant dispenser may be ruggedized for use in hostile environments such as those that may be anticipated for military applications. | 06-21-2012 |
20130177477 | DECONTAMINANT DISPENSER SUITABLE FOR USE AS A PROJECTILE - The disclosed invention relates to a decontaminant dispenser which may be used as a projectile. The invention also relates to a decontamination process using the decontaminant dispenser. The decontaminant dispenser may be thrown by hand, launched as an artillery shell or the payload for a missile, or dropped by an airplane into the area to be decontaminated. The dispenser may be placed in the area to be decontaminated. The decontaminant dispenser may be ruggedized for use in hostile environments such as those that may be anticipated for military applications. | 07-11-2013 |
Patent application number | Description | Published |
20160067148 | GASTRIC SYSTEMS, APPARATUS, AND METHODS FOR USE WITH ENTERAL FEEDING - Systems, methods, and apparatus for gastric pressure relief, flow regulation, location, gastric residual volume, a placement reminder, bidirectional fluid flow markings, reintroducing gastric material, collection reservoir raising, collection reservoir hanging, a drain port, setting tube length, and vent membranes. A gastric pressure relief system is used in connection with an enteral feeding system, which includes a feeding container, administration tubing and a delivery tube, where the gastric pressure relief system is interposed between the administration tubing and the delivery tube. The gastric pressure relief system includes a collection reservoir with a gas vent to ambient atmosphere, relief tubing secured to both the collection reservoir and a multi-way connector. The multi-way connector joins the administration tubing to the relief tubing and a delivery tube at a point below a patient's stomach, which is designated on a placement reminder apparatus. | 03-10-2016 |
Patent application number | Description | Published |
20120068068 | CHARGED PARTICLE DETECTORS - Disclosed are devices, systems, and methods are disclosed that include: (a) a first material layer positioned on a first surface of a support structure and configured to generate secondary electrons in response to incident charged particles that strike the first layer, the first layer including an aperture configured to permit a portion of the incident charged particles to pass through the aperture; and (b) a second material layer positioned on a second surface of the support structure and separated from the first layer by a distance of 0.5 cm or more, the second layer being configured to generate secondary electrons in response to charged particles that pass through the aperture and strike the second layer, where the device is a charged particle detector. | 03-22-2012 |
20130118184 | COOLED CHARGED PARTICLE SYSTEMS AND METHODS - Cooled charged particle sources and methods are disclosed. In some embodiments, a charged particle source is thermally coupled to a solid cryogen, such as solid nitrogen. The thermal coupling can be design to provide good thermal conductivity to maintain the charged particle source at a desirably low temperature. | 05-16-2013 |
20160104598 | Charged Particle Beam System and Method of Operating a Charged Particle Beam System - The present disclosure relates to a gas field ion source comprising a housing, an electrically conductive tip arranged within the housing, a gas supply for supplying one or more gases to the housing, wherein the one or more gases comprise neon or a noble gas with atoms having a mass larger than neon, and an extractor electrode having a hole to permit ions generated in the neighborhood of the tip to pass through the hole. A surface of the extractor electrode facing the tip can be made of a material having a negative secondary ion sputter rate of less than 10 | 04-14-2016 |